Cargando…

An in-depth examination of funded and unfunded cognitive pharmaceutical services

BACKGROUND: A substantial expansion in the scope of practice of community pharmacists has become evident over the years, with increased government remuneration pledged to support cognitive pharmaceutical services (CPS) delivery as part of the Australian Community Pharmacy Agreements. Exploring exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Vivien, Krass, Ines, Aslani, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032079/
https://www.ncbi.nlm.nih.gov/pubmed/35480617
http://dx.doi.org/10.1016/j.rcsop.2021.100060
_version_ 1784692551907803136
author Tong, Vivien
Krass, Ines
Aslani, Parisa
author_facet Tong, Vivien
Krass, Ines
Aslani, Parisa
author_sort Tong, Vivien
collection PubMed
description BACKGROUND: A substantial expansion in the scope of practice of community pharmacists has become evident over the years, with increased government remuneration pledged to support cognitive pharmaceutical services (CPS) delivery as part of the Australian Community Pharmacy Agreements. Exploring experiences in providing funded and unfunded CPS within the existing work environment will enable better understanding of community pharmacists' roles and responsibilities in delivering CPS. OBJECTIVE: To explore pharmacists' roles, responsibilities, experiences, and perceived impact associated with delivering CPS. METHODS: Qualitative semi-structured interviews (n = 25) were conducted with practising community pharmacists in Australia who were engaged in delivering CPS during the time when the Sixth Community Pharmacy Agreement (6CPA) was in effect. Verbatim transcripts were thematically analysed (inductive analysis). RESULTS: All participants reported an expansion of services being provided in community pharmacies. Pharmacists offered a broad range of CPS within the community pharmacy setting, via 6CPA-funded and non-6CPA or unfunded initiatives. Almost all participants reported that their pharmacy provided 6CPA-funded initiatives such as dose administration aids, clinical interventions, MedsChecks/Diabetes MedsChecks, and Home Medicines Reviews. User-pay services being offered included pharmacist-led flu vaccinations, opioid substitution therapy, sleep apnoea services, and absence from work certificates, among other services. However, profit margins on user-pay services were minimal. CPS provision was seen to have positive impacts at patient and health care system levels. Pharmacists felt they enabled timely and convenient access to health care for patients in the community pharmacy setting, and facilitated quality use of medicines, which in turn had positive impact on the community pharmacy business. CONCLUSIONS: A prominent shift in the provision of CPS was evident. Professional services provision has become the status quo for the practice of the profession, indicative of a likely shift in the work value of community pharmacists. Pharmacists should be further recognised professionally and financially for their contributions as health care professionals within the broader health care system.
format Online
Article
Text
id pubmed-9032079
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90320792022-04-26 An in-depth examination of funded and unfunded cognitive pharmaceutical services Tong, Vivien Krass, Ines Aslani, Parisa Explor Res Clin Soc Pharm Article BACKGROUND: A substantial expansion in the scope of practice of community pharmacists has become evident over the years, with increased government remuneration pledged to support cognitive pharmaceutical services (CPS) delivery as part of the Australian Community Pharmacy Agreements. Exploring experiences in providing funded and unfunded CPS within the existing work environment will enable better understanding of community pharmacists' roles and responsibilities in delivering CPS. OBJECTIVE: To explore pharmacists' roles, responsibilities, experiences, and perceived impact associated with delivering CPS. METHODS: Qualitative semi-structured interviews (n = 25) were conducted with practising community pharmacists in Australia who were engaged in delivering CPS during the time when the Sixth Community Pharmacy Agreement (6CPA) was in effect. Verbatim transcripts were thematically analysed (inductive analysis). RESULTS: All participants reported an expansion of services being provided in community pharmacies. Pharmacists offered a broad range of CPS within the community pharmacy setting, via 6CPA-funded and non-6CPA or unfunded initiatives. Almost all participants reported that their pharmacy provided 6CPA-funded initiatives such as dose administration aids, clinical interventions, MedsChecks/Diabetes MedsChecks, and Home Medicines Reviews. User-pay services being offered included pharmacist-led flu vaccinations, opioid substitution therapy, sleep apnoea services, and absence from work certificates, among other services. However, profit margins on user-pay services were minimal. CPS provision was seen to have positive impacts at patient and health care system levels. Pharmacists felt they enabled timely and convenient access to health care for patients in the community pharmacy setting, and facilitated quality use of medicines, which in turn had positive impact on the community pharmacy business. CONCLUSIONS: A prominent shift in the provision of CPS was evident. Professional services provision has become the status quo for the practice of the profession, indicative of a likely shift in the work value of community pharmacists. Pharmacists should be further recognised professionally and financially for their contributions as health care professionals within the broader health care system. Elsevier 2021-08-08 /pmc/articles/PMC9032079/ /pubmed/35480617 http://dx.doi.org/10.1016/j.rcsop.2021.100060 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Tong, Vivien
Krass, Ines
Aslani, Parisa
An in-depth examination of funded and unfunded cognitive pharmaceutical services
title An in-depth examination of funded and unfunded cognitive pharmaceutical services
title_full An in-depth examination of funded and unfunded cognitive pharmaceutical services
title_fullStr An in-depth examination of funded and unfunded cognitive pharmaceutical services
title_full_unstemmed An in-depth examination of funded and unfunded cognitive pharmaceutical services
title_short An in-depth examination of funded and unfunded cognitive pharmaceutical services
title_sort in-depth examination of funded and unfunded cognitive pharmaceutical services
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032079/
https://www.ncbi.nlm.nih.gov/pubmed/35480617
http://dx.doi.org/10.1016/j.rcsop.2021.100060
work_keys_str_mv AT tongvivien anindepthexaminationoffundedandunfundedcognitivepharmaceuticalservices
AT krassines anindepthexaminationoffundedandunfundedcognitivepharmaceuticalservices
AT aslaniparisa anindepthexaminationoffundedandunfundedcognitivepharmaceuticalservices
AT tongvivien indepthexaminationoffundedandunfundedcognitivepharmaceuticalservices
AT krassines indepthexaminationoffundedandunfundedcognitivepharmaceuticalservices
AT aslaniparisa indepthexaminationoffundedandunfundedcognitivepharmaceuticalservices